Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2008 | 1 |
2012 | 1 |
2017 | 1 |
2019 | 1 |
2020 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Platinum-Fluoropyrimidine and Paclitaxel-Based Chemotherapy in the Treatment of Advanced Anal Cancer Patients.
Oncologist. 2017 Apr;22(4):402-408. doi: 10.1634/theoncologist.2016-0241. Epub 2017 Feb 16.
Oncologist. 2017.
PMID: 28209745
Free PMC article.
Five-year OS in the overall population was 15% (95% CI, 7.0%-25.0%). Age 65 years and liver metastases were predictive of better PFS (hazard ratio [HR], 0.39; 95% CI, 0.16-0.97; p = .04) and worse OS (HR, 2.25; 95% CI, 1.25-4.03; p = .01), respectively. ...Clinical trials …
Five-year OS in the overall population was 15% (95% CI, 7.0%-25.0%). Age 65 years and liver metastases were predictive of better PFS …
Treatment options in metastatic squamous cell carcinoma of the anal canal.
Eng C, Pathak P.
Eng C, et al.
Curr Treat Options Oncol. 2008 Dec;9(4-6):400-7. doi: 10.1007/s11864-009-0103-7. Epub 2009 May 29.
Curr Treat Options Oncol. 2008.
PMID: 19479383
Item in Clipboard
Relapsed refractory metastatic squamous cell cancer of anal canal in a patient with retroviral infection responding to cetuximab.
Lerner J, Michel M, Dasanu CA.
Lerner J, et al.
J Oncol Pharm Pract. 2020 Jun;26(4):1025-1028. doi: 10.1177/1078155219884605. Epub 2019 Nov 4.
J Oncol Pharm Pract. 2020.
PMID: 31684821
Item in Clipboard
Does gap-free intensity modulated chemoradiation therapy provide a greater clinical benefit than 3D conformal chemoradiation in patients with anal cancer?
Dewas CV, Maingon P, Dalban C, Petitfils A, Peignaux K, Truc G, Martin E, Khoury C, Dewas S, Créhange G.
Dewas CV, et al.
Radiat Oncol. 2012 Nov 29;7:201. doi: 10.1186/1748-717X-7-201.
Radiat Oncol. 2012.
PMID: 23190693
Free PMC article.
IMRT makes it possible to remove the gap, but with no impact on the prognosis. Nonetheless, a longer follow-up is essential to determine whether or not IMRT has an impact on late toxicity, local control and survival compared with conventional 3D-CRT....
IMRT makes it possible to remove the gap, but with no impact on the prognosis. Nonetheless, a longer follow-up is essential to determ …
Item in Clipboard
Cite
Cite